Epleron 25 mg is a prescription medication indicated for the management of congestive heart failure following an acute myocardial infarction and for hypertension. Belonging to the class of potassium-sparing diuretics and aldosterone antagonists, Epleron helps regulate blood pressure and improve cardiovascular outcomes by modulating the renin-angiotensin-aldosterone system.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class:

• Potassium-sparing diuretics

• Aldosterone antagonists

Mechanism of Action:
Epleron 25 mg selectively binds to mineralocorticoid receptors, inhibiting the action of aldosterone. By blocking aldosterone in epithelial (kidney, GI tract) and nonepithelial (heart, blood vessels, brain) tissues, Epleron reduces sodium reabsorption, prevents water retention, and mitigates vascular remodeling and endothelial dysfunction, ultimately helping to control blood pressure and protect the cardiovascular system.

Indications:

• Congestive heart failure after acute myocardial infarction

• Hypertension

Dosage & Administration:

• Congestive Heart Failure: Initiate at 25 mg once daily, titrating to 50 mg once daily over 4 weeks as tolerated.

• Hypertension: Start at 50 mg once daily. If necessary, increase to 50 mg twice daily. Higher doses are not recommended due to risk of hyperkalemia.

• Can be taken with or without food.

Contraindications:

• Hyperkalemia

• Severe renal or hepatic impairment

• Concurrent use with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin)

• Use with other potassium-sparing diuretics

Precautions & Warnings:

• Use cautiously in patients with hyperkalemia, severe kidney disease, or diabetes with proteinuria.

• Monitor electrolytes, especially potassium, during therapy.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Potential Drug Interactions:

• Increased risk of hyperkalemia with ACE inhibitors, ARBs, ciclosporin, tacrolimus, or trimethoprim

• Reduced antihypertensive effect with NSAIDs or glucocorticoids

• Enhanced hypotensive effect with α1-blockers, TCAs, or other hypotensive agents

• Increased plasma levels with CYP3A4 inhibitors (e.g., fluconazole, verapamil)

Side Effects:
Common: headache, dizziness, diarrhea, stomach pain, nausea, cough, or flu-like symptoms.
Serious: rash, itching, swelling, severe dizziness, or difficulty breathing (seek immediate medical attention).

Pregnancy & Lactation:

• Pregnancy: Use only if potential benefit outweighs risk.

• Lactation: Unknown excretion in human milk; weigh the benefits of therapy against potential risks to the infant.

Special Populations:

• Pediatric: Safety and efficacy not established

• Geriatric: No significant differences in efficacy or safety observed

Overdose:
Symptoms may include hyperkalemia and hypotension. Management includes symptomatic treatment, activated charcoal if appropriate, and standard hyperkalemia therapy.

Storage:
Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Drug Classes:
Potassium-sparing diuretics & aldosterone antagonists.